Shandong TheraWisdom Biopharma Co., Ltd.
4 clinical trials · Sponsor
◉ Watch Shandong TheraWisdom Biopharma Co., Ltd.
| Record | Firm | Date |
|---|---|---|
| Safety, Tolerability, PK, PD, Immunogenicity and Efficacy of TWP-102 in Patients With Advanced Malignancies. (NCT05024305) | Shandong TheraWisdom Biopharma Co., Ltd. | 2022-03-08 |
| The Safety and Efficacy of TWP-101 in Patients With Advanced Solid Tumor (NCT04871347) | Shandong TheraWisdom Biopharma Co., Ltd. | 2021-08-30 |
| Safety and Tolerability of TWP-201 in Healthy Female Subjects (NCT04878705) | Shandong TheraWisdom Biopharma Co., Ltd. | 2021-05-17 |
| Safety, Tolerability and Pharmacokinetics of TWP-101 in Patients With Advanced Melanoma and Urothelial Carcinoma (NCT04871334) | Shandong TheraWisdom Biopharma Co., Ltd. | 2021-02-07 |
Track Shandong TheraWisdom Biopharma Co., Ltd. automatically
Every clearance here is in the API, with alerts when new ones post.